BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Talks.cam//talks.cam.ac.uk//
X-WR-CALNAME:Talks.cam
BEGIN:VEVENT
SUMMARY:Opportunities and challenges of pharmacogenomics at scale in a nat
 ional health service - William Newman (University of Manchester)
DTSTART:20260316T143000Z
DTEND:20260316T153000Z
UID:TALK245290@talks.cam.ac.uk
CONTACT:Spencer Keene
DESCRIPTION:Abstract: Over the past decades many genetic variants have bee
 n identified that alter individuals’ responses to their medication resul
 ting in ineffective treatment or adverse drug reactions. In England\, thro
 ugh the NHS Network of Excellence in Pharmacogenomics\, we have developed 
 an implementation science program to adopt pharmacogenomics into routine c
 linical use. This has focused on the type of genetic test\, the way that t
 he data is transferred into an actionable format for the clinician\, and d
 etermining the clinical outcomes of this intervention.\n\nIn this talk\, I
  will discuss the clinical contexts of pharmacogenomics and how a new way 
 of presenting genomic data is required for adoption at scale that is accep
 table to both patients and health professionals. I will explore the use of
  point of care genetic testing and the potential for pre-emptive testing t
 o improve medicines optimisation.\n\n\n\nBio: Bill is a clinician scientis
 t. Professor of Translational Genomic medicine at the University of Manche
 ster and a Consultant in Clinical Genetics at the Manchester Centre for Ge
 nomic Medicine.  He has a multidisciplinary research program in the implem
 entation of pharmacogenomics in clinical practice and is the lead of the N
 HS England Network of Excellence in Pharmacogenomics and Medicines Optimis
 ation. He is the immediate past President of the European Society of Human
  Genetics.\n
LOCATION:Heart and Lung Research Institute (0.R089)
END:VEVENT
END:VCALENDAR